These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23541026)

  • 1. Preclinical evaluation of NETA-based bifunctional ligand for radioimmunotherapy applications using 212Bi and 213Bi: radiolabeling, serum stability, and biodistribution and tumor uptake studies.
    Kang CS; Song HA; Milenic DE; Baidoo KE; Brechbiel MW; Chong HS
    Nucl Med Biol; 2013 Jul; 40(5):600-5. PubMed ID: 23541026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and preclinical evaluation of bifunctional ligands for improved chelation chemistry of 90Y and 177Lu for targeted radioimmunotherapy.
    Kang CS; Sun X; Jia F; Song HA; Chen Y; Lewis M; Chong HS
    Bioconjug Chem; 2012 Sep; 23(9):1775-82. PubMed ID: 22881720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient bifunctional decadentate ligand 3p-C-DEPA for targeted α-radioimmunotherapy applications.
    Song HA; Kang CS; Baidoo KE; Milenic DE; Chen Y; Dai A; Brechbiel MW; Chong HS
    Bioconjug Chem; 2011 Jun; 22(6):1128-35. PubMed ID: 21604692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel bimodal bifunctional ligands for radioimmunotherapy and targeted MRI.
    Chong HS; Song HA; Ma X; Milenic DE; Brady ED; Lim S; Lee H; Baidoo K; Cheng D; Brechbiel MW
    Bioconjug Chem; 2008 Jul; 19(7):1439-47. PubMed ID: 18564868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of a new bifunctional NETA chelate for molecular targeted radiotherapy using(90)Y or(177)Lu.
    Kang CS; Chen Y; Lee H; Liu D; Sun X; Kweon J; Lewis MR; Chong HS
    Nucl Med Biol; 2015 Mar; 42(3):242-9. PubMed ID: 25487552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of a bifunctional chelate for development of Bi(III)-labeled radioimmunoconjugates.
    Dadwal M; Kang CS; Song HA; Sun X; Dai A; Baidoo KE; Brechbiel MW; Chong HS
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7513-5. PubMed ID: 22047687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design and generation of a bimodal bifunctional ligand for antibody-targeted radiation cancer therapy.
    Chong HS; Ma X; Le T; Kwamena B; Milenic DE; Brady ED; Song HA; Brechbiel MW
    J Med Chem; 2008 Jan; 51(1):118-25. PubMed ID: 18062661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and comparative biological evaluation of bifunctional ligands for radiotherapy applications of (90)Y and (177)Lu.
    Chong HS; Sun X; Chen Y; Sin I; Kang CS; Lewis MR; Liu D; Ruthengael VC; Zhong Y; Wu N; Song HA
    Bioorg Med Chem; 2015 Mar; 23(5):1169-78. PubMed ID: 25648683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A highly effective bifunctional ligand for radioimmunotherapy applications.
    Chong HS; Song HA; Kang CS; Le T; Sun X; Dadwal M; Lee H; Lan X; Chen Y; Dai A
    Chem Commun (Camb); 2011 May; 47(19):5584-6. PubMed ID: 21468393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of novel ligands for radioimmunotherapy.
    Chong HS; Milenic DE; Garmestani K; Brady ED; Arora H; Pfiester C; Brechbiel MW
    Nucl Med Biol; 2006 May; 33(4):459-67. PubMed ID: 16720237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and normal tissue toxicity of Auger electron (AE) radioimmunotherapy (RIT) with [
    Chan C; Fonge H; Lam K; Reilly RM
    Nucl Med Biol; 2020; 80-81():37-44. PubMed ID: 31706737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient synthesis and evaluation of bimodal ligand NETA.
    Chong HS; Song HA; Birch N; Le T; Lim S; Ma X
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3436-9. PubMed ID: 18445528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3p-C-NETA: A versatile and effective chelator for development of Al
    Ahenkorah S; Murce E; Cawthorne C; Ketchemen JP; Deroose CM; Cardinaels T; Seimbille Y; Fonge H; Gsell W; Bormans G; Ooms M; Cleeren F
    Theranostics; 2022; 12(13):5971-5985. PubMed ID: 35966589
    [No Abstract]   [Full Text] [Related]  

  • 14. Radiochemical and Biological Evaluation of 3p-
    Murce E; Ahenkorah S; Beekman S; Handula M; Stuurman D; de Ridder C; Cleeren F; Seimbille Y
    Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
    Su FM; Beaumier P; Axworthy D; Atcher R; Fritzberg A
    Nucl Med Biol; 2005 Oct; 32(7):741-7. PubMed ID: 16243650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu.
    Price EW; Zeglis BM; Lewis JS; Adam MJ; Orvig C
    Dalton Trans; 2014 Jan; 43(1):119-31. PubMed ID: 24104523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.
    Hartmann F; Horak EM; Garmestani K; Wu C; Brechbiel MW; Kozak RW; Tso J; Kosteiny SA; Gansow OA; Nelson DL
    Cancer Res; 1994 Aug; 54(16):4362-70. PubMed ID: 8044783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for
    Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (212)Pb-radioimmunotherapy induces G(2) cell-cycle arrest and delays DNA damage repair in tumor xenografts in a model for disseminated intraperitoneal disease.
    Yong KJ; Milenic DE; Baidoo KE; Brechbiel MW
    Mol Cancer Ther; 2012 Mar; 11(3):639-48. PubMed ID: 22238365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.